INNOV'NCARE
Liquidation judiciaire since 24 Jun 2026
Business purpose.
- L'invention, la fabrication, le développement et le commerce de produits thérapeutiques, pharmaceutiques, diagnostiques, théranostiques, d'imagerie ou de dispositifs médicaux, en santé humaine et animale, dans le domaine des cancers et des maladies rares et dans le domaine de la neurologie, et notamment dans le ciblage et la maturation des cellules souches.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Manufacture of pharmaceutical preparations (21.20Z)
- Sector
- Manufacture of basic pharmaceutical products and pharmaceutical preparations
- Headcount
- Headcount unknown
- Created
- 21 May 2025
- Share capital
- 1,000.00 EUR (variable)
- Financial year end
- 31/12
- Establishments
- 1
Directors
- GLIOMED CAPITAL President de SAS
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
20 / 100 E
Confidence: high
Ongoing insolvency proceedings cap this score, whatever the other components say.
- No insolvency proceedings
- 0.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (1.5 years)
- 3.0 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in August 2026
Legal notices
-
Insolvency proceedings 30 Jun 2026
- Court :
- Greffe du Tribunal de Commerce d'Angers
- Nature :
- Jugement d'ouverture de liquidation judiciaire
- Date of judgment :
- 24/06/2026
- Detail :
- Jugement prononçant la liquidation judiciaire , date de cessation des paiements le 22 Mai 2026, désignant liquidateur SELARL LEX MJ, prise en la personne de Maître Lucie MARGOTTIN 11, rue Jean Bodin - CS 80502 - 49105 Angers . Les créances sont à adresser, dans les deux mois de la présente publication, auprès du liquidateur ou sur le portail électronique prévu par les articles L. 814-2 et L. 814-13 du code de commerce.
BODACC A n 20260122, annonce n 4223 · Proof of publication (PDF)
-
Incorporation 2 Jun 2025
- Court :
- Greffe du Tribunal de Commerce d'Angers
BODACC A n 20250105, annonce n 1917 · Proof of publication (PDF)
Filings and accounts
- Formality 5 Dec 2025
- Formality 26 May 2025
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- proceedings (empty) → Liquidation judiciaire 1 Oct 2026
Frequently asked questions about INNOV'NCARE
- What is the SIREN number of INNOV'NCARE?
- The SIREN number of INNOV'NCARE is 944869007. Its intra-community VAT number is FR89944869007.
- Where is the head office of INNOV'NCARE?
- Head office address: 47 RUE DES CAPUCINS, 49100 ANGERS.
- When was INNOV'NCARE founded?
- INNOV'NCARE was founded on 21 May 2025.
- What does INNOV'NCARE do?
- Its declared main activity is: Manufacture of pharmaceutical preparations (NAF code 21.20Z).
- Who runs INNOV'NCARE?
- The officer listed in the register is GLIOMED CAPITAL (President de SAS).
- Is INNOV'NCARE subject to insolvency proceedings?
- Yes: Liquidation judiciaire. Opening judgment dated 24 Jun 2026.